<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian journal of Pediatric Hematology and Oncology</title>
<title_fa>Iranian journal of Pediatric Hematology and Oncology</title_fa>
<short_title>Iran J Ped Hematol Oncol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpho.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-8892</journal_id_issn>
<journal_id_issn_online>2228-6993</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Early Detection of Renal Dysfunction in β Thalassemia with Focus on Novel Biomarkers</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;Improved survival among transfusion dependent thalassemia patients in recent years has led to the manifestation of morbidities such as renal dysfunction. Renal injury is still an underestimated complication in &amp;beta; thalassemia major patients. Chronic anemia, iron overload due to repeated transfusion, and specific iron chelators are the main factors in pathogenesis of renal dysfunction in &amp;beta; thalassemia. Early identification of this morbidity allows us to delay the progression of kidney damage and therefore reduce renal impairment. In recent decades , novel biomarkers for early recognition of renal dysfunction have been studied in thalassemic patients, such as cystatin C, beta 2 microglobulin , alpha 1 microglobulin, N-acetyl beta-D-glucosaminidase (NAG), neutrophil gelatinase associated lipocaline (NGAL) , kidney injury molecule 1 (KIM-1) , liver type fatty acid binding protein (L-FABP), and retinol binding protein (RBP). In this review, renal aspects of thalassemia with focus on novel biomarkers were discussed.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>: β thalassemia , Biomarkers, Renal Insufficiency</keyword>
	<start_page>57</start_page>
	<end_page>68</end_page>
	<web_url>http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-686-3&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mozhgan </first_name>
	<middle_name></middle_name>
	<last_name>Hashemieh </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0003-1109-7285 </orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa>Shahid Beheshti University of Medical Sciences</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
